Stress markers predict mortality in patients with nonspecific complaints presenting to the emergency department and may be a useful risk stratification tool to support disposition planning

Academic Emergency Medicine

Volumn 20, Issue 7, 2013, Pages 670-679

  Nickel, Christian H ^a   Messmer, Anna S ^a   Geigy, Nicolas ^b   Misch, Franziska ^a   Mueller, Beat ^d   Dusemund, Frank ^d   Hertel, Sabine ^c   Hartmann, Oliver ^c   Giersdorf, Sven ^c   Bingisser, Roland ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Emergency Department   (Switzerland)

^c Research Department   (Germany)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COPEPTIN; PEROXIREDOXIN 4; PROADRENOMEDULLIN;

AGED; ALGORITHM; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EMERGENCY CARE; EMERGENCY WARD; FEMALE; FOLLOW UP; GERIATRIC CARE; GERIATRIC HOSPITAL; GROUPS BY AGE; HOSPITAL DISCHARGE; HUMAN; LABORATORY DEVICE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT TRANSPORT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SIMULATION; SURVIVOR; SWITZERLAND; TERTIARY HEALTH CARE; TREATMENT PLANNING; VALIDATION STUDY;

ACUTE DISEASE; ADRENOMEDULLIN; AGED; AGED, 80 AND OVER; ALGORITHMS; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; EMERGENCY SERVICE, HOSPITAL; FATIGUE; FEMALE; GERIATRIC ASSESSMENT; GLYCOPEPTIDES; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; LENGTH OF STAY; MALE; MULTIVARIATE ANALYSIS; PEROXIREDOXINS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STRESS, PSYCHOLOGICAL; SURVIVAL ANALYSIS; SWITZERLAND;

EID: 84880276670     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/acem.12172     Document Type: Article

References (49)

1. Covinsky KE, Palmer RM, Fortinsky RH, et al. Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. J Am Geriatr Soc. 2003; 51: 451-8. (Pubitemid 36457342)
2. Mudge AM, O'Rourke P, Denaro CP,. Timing and risk factors for functional changes associated with medical hospitalization in older patients. J Gerontol A Biol Sci Med Sci. 2010; 65: 866-72.
3. Salvi F, Morichi V, Grilli A, Giorgi R, De Tommaso G, Dessi-Fulgheri P,. The elderly in the emergency department: a critical review of problems and solutions. Intern Emerg Med. 2007; 2: 292-301.
4. Samaras N, Chevalley T, Samaras D, Gold G,. Older patients in the emergency department: a review. Ann Emerg Med. 2010; 56: 261-9.
5. Aminzadeh F, Dalziel WB,. Older adults in the emergency department: a systematic review of patterns of use, adverse outcomes, and effectiveness of interventions. Ann Emerg Med. 2002; 39: 238-47. (Pubitemid 34219636)
6. Wilber ST, Blanda M, Gerson LW,. Does functional decline prompt emergency department visits and admission in older patients? Acad Emerg Med. 2006; 13: 680-2. (Pubitemid 43729867)
7. Rutschmann OT, Chevalley T, Zumwald C, Luthy C, Vermeulen B, Sarasin FP,. Pitfalls in the emergency department triage of frail elderly patients without specific complaints. Swiss Med Wkly. 2005; 135: 145-50. (Pubitemid 40461245)
8. Grossmann FF, Zumbrunn T, Frauchiger A, Delport K, Bingisser R, Nickel CH,. At risk of undertriage? Testing the performance and accuracy of the Emergency Severity Index in elderly ED patients. Ann Emerg Med. 2012; 60: 317-25.
9. Mitra B, Cameron PA, Archer P, et al. The association between time to disposition plan in the emergency department and in-hospital mortality of general medical patients. Intern Med J. 2012; 42: 444-50.
10. Nemec M, Koller MT, Nickel CH, et al. Patients presenting to the emergency department with non-specific complaints: the Basel Non-specific Complaints (BANC) study. Acad Emerg Med. 2010; 17: 284-92.
11. Nickel CH, Nemec M, Bingisser R,. Weakness as presenting symptom in the emergency department. Swiss Med Wkly. 2009; 139: 271-2.
12. Ouslander JG, Lamb G, Perloe M, et al. Potentially avoidable hospitalizations of nursing home residents: frequency, causes, and costs [see editorial comments by Drs. Jean F. Wyman and William R. Hazzard, pp 760-761]. J Am Geriatr Soc. 2010; 58: 627-35.
13. Fernandez HM, Callahan KE, Likourezos A, Leipzig RM,. House staff member awareness of older inpatients' risks for hazards of hospitalization. Arch Intern Med. 2008; 168: 390-6. (Pubitemid 351347131)
14. Nickel CH, Ruedinger J, Misch F, et al. Copeptin and peroxiredoxin-4 independently predict mortality in patients with nonspecific complaints presenting to the emergency department. Acad Emerg Med. 2011; 18: 851-9.
15. Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993; 192: 553-60. (Pubitemid 23227359)
16. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T,. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 1994; 338: 6-10. (Pubitemid 24047772)
17. Lainchbury JG, Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG,. Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers. J Clin Endocrinol Metab. 2000; 85: 1016-20. (Pubitemid 32269342)
18. Marutsuka K, Nawa Y, Asada Y, et al. Adrenomedullin and proadrenomudullin N-terminal 20 peptide (PAMP) are present in human colonic epithelia and exert an antimicrobial effect. Exp Physiol. 2001; 86: 543-5. (Pubitemid 32910341)
19. Struck J, Tao C, Morgenthaler NG, Bergmann A,. Identification of an adrenomedullin precursor fragment in plasma of sepsis patients. Peptides. 2004; 25: 1369-72. (Pubitemid 39180069)
20. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Muller B,. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care. 2005; 9: R816-24.
21. Schuetz P, Wolbers M, Christ-Crain M, et al. Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections. Crit Care. 2010; 14: R106.
22. Huang DT, Angus DC, Kellum JA, et al. Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia. Chest. 2009; 136: 823-31.
23. Kobayashi K, Kitamura K, Etoh T, et al. Increased plasma adrenomedullin levels in chronic congestive heart failure. Am Heart J. 1996; 131: 994-8. (Pubitemid 26135766)
24. Nagaya N, Nishikimi T, Uematsu M, et al. Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction. Heart. 1999; 81: 483-7. (Pubitemid 29234307)
25. Potocki M, Breidthardt T, Reichlin T, et al. Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study. Crit Care. 2009; 13: R122.
26. Ishihara T, Yokota N, Hisanaga S, et al. Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure. Clin Nephrol. 1999; 52: 119-23. (Pubitemid 29387168)
27. Kinoshita H, Fujimoto S, Kitamura K, et al. Increased plasma levels of mature adrenomedullin in chronic glomerulonephritis. Nephron. 2000; 86: 333-8.
28. Grossmann FF, Nickel CH, Christ M, Schneider K, Spirig R, Bingisser R,. Transporting clinical tools to new settings: cultural adaptation and validation of the Emergency Severity Index in German. Ann Emerg Med. 2011; 57: 257-64.
29. Katz S, Akpom CA,. Index of activities of daily living (ADL). Med Care. 1976; 14: 116-8.
30. Morgenthaler NG, Struck J, Alonso C, Bergmann A,. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem. 2005; 51: 1823-9. (Pubitemid 41368172)
31. Caruhel P, Mazier C, Kunde J, Morgenthaler NG, Darbouret B,. Homogeneous time-resolved fluoroimmunoassay for the measurement of midregional proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S KRYPTOR. Clin Biochem. 2009; 42: 725-8.
32. Morgenthaler NG, Struck J, Alonso C, Bergmann A,. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem. 2006; 52: 112-9. (Pubitemid 43032474)
33. Albrich W, Dusemund F, Ruegger K, et al. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis. 2011; 11: 112.
34. Chew WM, Birnbaumer DM,. Evaluation of the elderly patient with weakness: an evidence based approach. Emerg Med Clin North Am. 1999; 17: 265-78. (Pubitemid 29147016)
35. Carpenter CR, Heard K, Wilber S, et al. Research priorities for high-quality geriatric emergency care: medication management, screening, and prevention and functional assessment. Acad Emerg Med. 2011; 18: 644-54.
36. Hogan TM, Losman ED, Carpenter CR, et al. Development of geriatric competencies for emergency medicine residents using an expert consensus process. Acad Emerg Med. 2010; 17: 316-24.
37. Chun TH, Itoh H, Saito T, et al. Oxidative stress augments secretion of endothelium-derived relaxing peptides, C-type natriuretic peptide and adrenomedullin. J Hypertens. 2000; 18: 575-80. (Pubitemid 30303488)
38. Sugo S, Minamino N, Shoji H, et al. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun. 1995; 207: 25-32.
39. Sugo S, Minamino N, Shoji H, Kangawa K, Matsuo H,. Effects of vasoactive substances and cAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cells. FEBS Lett. 1995; 369: 311-4.
40. Jougasaki M, Wei CM, Aarhus LL, Heublein DM, Sandberg SM, Burnett JC Jr,. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am J Physiol. 1995; 268: F657-63.
41. Hinson JP, Kapas S, Smith DM,. Adrenomedullin, a multifunctional regulatory peptide. Endocrine Rev. 2000; 21: 138-67. (Pubitemid 32275593)
42. Linscheid P, Seboek D, Zulewski H, Keller U, Muller B,. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology. 2005; 146: 2699-708. (Pubitemid 40695573)
43. Schulte J, Struck J, Kohrle J, Muller B,. Circulating levels of peroxiredoxin 4 as a novel biomarker of oxidative stress in patients with sepsis. Shock. 2011; 35: 460-5.
44. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB,. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010; 49: 1603-16.
45. Uno K, Nicholls SJ,. Biomarkers of inflammation and oxidative stress in atherosclerosis. Biomark Med. 2010; 4: 361-73.
46. Schulte J, Struck J, Bergmann A, Köhrle J,. Immunoluminometric assay for quantification of peroxiredoxin 4 in human serum. Clin Chim Acta. 2010; 411: 1258-63.
47. Schulte J,. Peroxiredoxin 4: a multifunctional biomarker worthy of further exploration. BMC Med. 2011; 9: 137.
48. Katan M, Morgenthaler N, Widmer I, et al. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinol Lett. 2008; 29: 341-6.
49. Nickel CH, Bingisser R, Morgenthaler NG,. The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med. 2012; 10: 7.